Baxter Healthcare Corporation

Baxter International, founded in 1931, is a global medical products and services company with expertise in medical devices, pharmaceuticals and biotechnology. The company, through its subsidiaries, assists health care professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, kidney disease, cancer, infectious diseases, trauma and other conditions. Baxter is a leading manufacturer of products for peritoneal dialysis, a home therapy for people with end-stage renal disease or irreversible kidney failure. The company also manufactures intravenous solutions and administration sets, premixed drugs and drug reconstitution systems, prefilled vials and syringes for injectable drugs, electronic infusion pumps, and other products used to deliver fluids and drugs to patients. Its biopharmaceutical products include plasma-based therapies to treat immune disorders, alpha 1 antitrypsin deficiency and other chronic blood-related conditions. Robert L. Parkinson Jr. has been the chief executive officer of Baxter International for more than two years. He has been with the health care equipment and services company for over two years. Parkinson earned a BA and MBA from Loyola University. Baxter International is located in Deerfield, Ill.